FDA Investigator Jacob G Lutz

Jacob G Lutz has inspections in 4 countries as of 29 Sep 2023. Jacob G Lutz has collaborated with a combinined 4565 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
33
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Israel, United States of America, Spain, Germany
Co-Investigator(s):
Adree N Anderson, Alan L Truong, Alan M Barker, Alan M Roberts, Alanna Lmussawwir Bias, Amy M Cramer, Amy S Graf, Ana E Morales, Ana Paulap Sandee, Anastasia M Shields, Andrew J Barrowcliff, Andrew J Lang, Annemarie Kleiza, Anthony F Lorenzo, Anthony R Bucks, Art O Czabaniuk, Atul J Agrawal, Aurora Miha Trifanov, Azza Talaat, Barbara Jwilimczyk Macri, Bei Y He, Brent M Dehaan, Brent T Hall, Brentley S Collins, Brett R Havranek, Brian D Nicholson, Brian P Putz, Brittany M Kershaw, Bruce H Mccullough, Bryan S Roddy, Carl A Huffman, III, Caroline H Le, Catherine V Quinlan, Cathie S Marshall, Chaoying C Ma, Charles I Ann, Charles L Zhou, Cheng H Yen, Christian D Lynch (CDL), Christina A Miller, Christopher D Leach, Cody J Alley, Constantin Y Philopoulos, Courtney E Hillier, Danial S Hutchison, Daniel J Brown, Daniel J Grabicki, Daniel J Lahar, Darla J Christopher, Darren S Morgan, David A Paterson, David J Gasparovich, David L Miser, David Perkins, Dawn C Olenjack, Deanna L Lampley, Deborah M Trout, Debra I Love, Denise M Digiulio, Diane R Weidley, Dogbeda F Mackenzie, Dr. Carmelo Rosa, Eboni S Funderburk, Eliezar Ramos, Elizabeth L Philpy, Elizabeth Ll Edwards, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Enrico Joset Mangahis, Eric C Nielsen, Eric M Mueller, PharmD, Eric T Huebler, Erika V Butler, Frederick Razzaghi, French, Gavin T Cua, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, German Rivera, Gwyn G Dickinson, Harperd, Hector A Carrero, Helen B Ricalde, Ismael Oera Lv, Ismael Olvera, IV, Jacob G Luts, Jacqueline Mdiaz Albertini, James B Arnett, James I Giefer, James K Ireland, James L Dunnie, Jr, James P Mcreavey, James R Evans, Janet L Bowen, Janete A Eaker, Janete A Oliveira, Jazmine N Still, Jeffrey A Sincek, Jeffrey A Sommers, Jeffrey D Meng, Jennifer M Gogley, Jessica E Hensley, Jessica M Monteiro, Jimmie L Weigand, Joohi Castelvetere, Jose Alopez Rubet, Joseph A Piechocki, Joseph R Lambert, Joseph T Madak, Joshua M Adams, Kevin D Kallander, Kristin M Abaonza, Kshitij A Patkar, Larry K Austin, Lata C Mathew, PhD, Laura S Huffman, Laureen F Kononen, Lauren M Lilly, PhD, Laurie A Haxel, Laurie B Frazier, Laurimer Kuilan Torres, LCDR Michael H Tollon, Lequita M Mayhew, Leslie A Paul, Lindsey Brown, PhD, Lisa L Flores, Logan T Williams, Lori J Silverstein, Lydia Irosas Marty, Maan S Abduldayem, Makini Cobourne Duval, PhD, Margaret M Annes, Maria Estrella, Maria Estrella Jimenez, Marion D Wimberly, Jr, Mark G Peterson, Martha Sullivan Myrick, Mary E Storch, Matthew B Casale, Matthew J Gretkierewicz, Matthew M Schuckmann, Maya M Davis, Meisha Waters, Miah I Schneider, Michael A Taylor, Michael E Maselli, Michael K Larson, Michael Shanks, MS, Michele L Forster, PhD, Michele L Glendenning, Michele Perry Williams, Mihaly S Ligmond, Minerva Rogers, Mishelle L Harriger, Mohsen Rajabi Abhari, FDA, Monica E Murie, Monica M Mcclure, Msdap Gonzlezk, Myra K Casey, Nancy L Neiger, Nicholas L Hunt, Nicholas P Diorio, Nicholas R Nance, Omotunde O Osunsanmi, Ou Ma, Patrick C Klotzbuecher, Patsy I Domingo, Patsy J Domingo, Paul L Bellamy, Paula A Trost, Peter R Lenahan, Philip A Klimkewicz, Phillip M Pontikos, Phung Thien Nguyen, Prabhu P Raju, Rachael A Moliver, Rafael Nevarez Nieves, Ralph A Erickson, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca Rodriguez, Reginald Walker, Renee L Rice, PhD, Richard W Thornton, Robert C Coleman, Robert D Tollefsen, Robert J Doyle, Robert J Ham, Robert M Barbosa, Robert R Barbosa, Robert Rodriguez, Rodney D Combs, Ronald G Crawford, Rose M Ashley, Ross J Grigsby, Russell J Glapion, Russell K Riley, Saied A Asbagh, Salwa K Poole, Sam H Haidar, PhD, Samina S Khan, Sandra A Boyd, Sandra A Hughes, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sargum C Sood, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Shafiq S Ahadi, Sherry G Bous, Shirley J Berryman, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Sinuet P Yashikiramoto, Sri Ramakrishnaiah Yellela, State Agency, Steven D Kehoe, Steven M Weinman, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Analyst, Tamil Arasu, PhD, Thai T Duong, Thomas A Peter, Thomas J Arista, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tina S Roecklein, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Tyra S Wisecup, Uttaniti Limchumroon (Tom), Veronica Fuentes, MS, Vilmary Negron Rodriguez, Walden H Lee, Warren J Lopicka, Wayne D Mcgrath, Wen Ning Chan (Sally), William C Gilbert, William D Tingley, Yvonne E Lozano, Zachary A Bogorad

Jacob G Lutz's Documents

Publish Date Document Type Title
November, 2021 FDA 483 Biological Research Solutions, Inc. - Form 483, 2021-11-29
July, 2022 EIR Cosmax USA, Inc. (Cosmax USA, Corporation) - EIR, 2022-07-22
September, 2022 FDA 483 Missouri Analytical Laboratories, Inc. - Form 483, 2022-09-02
October, 2019 FDA 483 LEXAMED - Form 483, 2019-10-10
September, 2021 FDA 483 Response GSK Consumer Health, Inc. - Form 483R, 2021-10-21
September, 2021 FDA 483 GSK Consumer Health, Inc. - Form 483, 2021-09-30
January, 2023 FDA 483 Response Avlon Industries Inc - Form 483R, 2023-01-24
November, 2022 FDA 483 Isotopia Molecular Imaging - Form 483, 2022-11-08
December, 2019 FDA 483 Apotheca Company - Form 483, 2019-12-06
October, 2019 FDA 483 King Pharmaceuticals LLC - Form 483, 2019-10-21
March, 2022 EIR Ferndale Laboratories, Inc. - EIR, 2022-03-04
March, 2022 FDA 483 Response Ferndale Laboratories, Inc. - Form 483R, 2022-03-23
January, 2023 FDA 483 Avlon Industries Inc - Form 483, 2023-01-24
December, 2021 FDA 483 Gilead Sciences, Inc. - Form 483, 2021-12-17
August, 2021 FDA 483 HNC Products Inc. - Form 483, 2021-08-24
September, 2022 FDA 483 Marcus Research Laboratory, Inc. - Form 483, 2022-09-02
June, 2022 FDA 483 Akron Coating & Adhesives - Form 483, 2022-06-27
December, 2022 FDA 483 Spartan Chemical Company, Inc. - Form 483, 2022-12-12
March, 2021 FDA 483 Spartan Chemical Company, Inc. - Form 483, 2021-03-26
April, 2022 EIR Rising Pharma Holdings, Inc. - EIR, 2022-04-08
December, 2021 EIR Gilead Sciences, Inc. - EIR, 2021-12-17
May, 2022 FDA 483 Metrex Research, LLC - Form 483, 2022-05-20
March, 2020 FDA 483 The Harvard Drug Group - Form 483, 2020-03-06
March, 2023 FDA 483 Snf Holdings, LLC - Form 483, 2023-03-02
April, 2023 FDA 483 Par Sterile Products LLC - Form 483, 2023-04-14
October, 2019 EIR LEXAMED - EIR, 2019-10-10
March, 2022 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2022-03-04
April, 2022 FDA 483 Rising Pharma Holdings, Inc. - Form 483, 2022-04-08
July, 2022 FDA 483 Cosmax USA, Inc. (Cosmax USA, Corporation) - Form 483, 2022-07-22
November, 2023 FDA 483 Catalent Indiana, LLC - Form 483, 2023-11-15
September, 2023 FDA 483 Grand River Aseptic Manufacturing - Form 483, 2023-09-29
June, 2023 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2023-06-16

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more